Insider · CIK 0002080825
Nicolas Claude Cary
Files at TONX (TON Strategy Co). First filing -, latest -.
In brief
Nicolas Claude Cary files SEC Form 4 as director at TONX (TON Strategy Co). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Nicolas Claude Cary has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 27, 2026 | TONX TON Strategy Co | AGrant or award Common Stock | +80,000 | $0.00 | $0 | 152,500 | Aug 28, 2026 |
| Jul 21, 2026 | TONX TON Strategy Co | AGrant or award Common Stock | +72,500 | $0.00 | $0 | 72,500 | Jul 22, 2026 |
| Apr 29, 2026 | TONX TON Strategy Co | JOther Common Stock | -14,803 | - | - | 0 | May 1, 2026 |
| Aug 7, 2025 | TONX TON Strategy Co | AGrant or award Common Stock | +14,803 | $0.00 | $0 | 14,803 | Aug 11, 2025 |
Questions about Nicolas Claude Cary
Answered from the filings on this page, as of the latest one.
Is Nicolas Claude Cary buying or selling?
Nicolas Claude Cary has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Nicolas Claude Cary's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Nicolas Claude Cary has 0.
Where does Nicolas Claude Cary file Form 4?
Nicolas Claude Cary has filed Form 4 at TONX (TON Strategy Co). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.